Case Report: Manuscript Writing


  • Biotherapy pharma company, Global, UK and US Clinical Development teams


  • Submit and publish pivotal trial data in a high impact factor journal (New England Journal of Medicine [NEJM]) on a very tight timeline.
  • Provide strategic guidance to the client regarding journal expectations, Good Publication Practice (GPP) guidelines, and reporting requirements for clinical trials.
  • Liaising with a very large author group (38 authors).


  • Using the clinical trial protocol, NEJM guidance for authors, and with reference to CONSORT requirements for reporting clinical trials, we produced a clear draft outline, and latterly produced all subsequent manuscript drafts.
  • Weekly status calls were held with the Clinical Development team, where the progress of the manuscript and other elements of the submission package were discussed.
  • Alchemy provided strategic guidance on reporting requirements and GPP – sometimes this required pushing back to ensure the information included complied with best practices and journal guidance, whilst maintaining the strict word limit.
  • The Alchemy team also liaised directly with the large authorship group to gather all information and approvals required for the submission.
  • Once all review rounds were complete, approvals received and tracked, and all author forms completed, the Alchemy team pressed ‘go’ on the submission.
  • We then liaised with key stakeholders to draft appropriate responses to peer-review and editor comments.
  • Finally, once the proof document was received, a full check was made vs the submitted manuscript to ensure no editorial changes affected the data or intended messaging.


  • An exceptionally high-quality manuscript was submitted to the NEJM.
  • We were able to satisfactorily address all editor and peer-review comments, and the manuscript was accepted and published.

Lesley and Adam are two of the best medical writers I’ve ever worked with.

Executive Director, Biotherapy pharma company

Related Case Studies

  • Medical Communications
    Interactive, virtual, internal training events

    Interactive, virtual, internal training events

    Dr Melissa Tombs

    Read More
  • Regulatory Writing
    Protocol Amendment – Large Oncology Platform Study for a Top 10 Pharma Company

    Protocol Amendment – Large Oncology Platform Study for a Top 10 Pharma Company

    Adam Taylor

    Read More

Looking for end-to-end manuscript writing support?

Our team of top-tier talent are adept in handling the whole project. We’re committed to best-in-class compliance and communication at every stage.

Get in Touch